The obese hypertensive: the weight of evidence against beta-blockers.
Williams
Bryan
B
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003503:Cyclobutanes / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D009765:Obesity / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine